发明名称 METHOD FOR INTENSIVE CARE OF MULTIPLE-ORGAN-FAILURE SYNDROME
摘要 FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly anesthesiology and intensive care, and can be used for treating multiple-organ-failure syndrome in the patients who underwent cardiac surgeries. That is ensured by evaluation of the risk factors of developing multiple-organ-failure syndrome. Their absence enables standard intensive care. If within 12 hours after the cardiac surgery there are observed acute reduced cardiac output and reduced ejection fraction with the combined introduction of adrenaline and dobutamine appeared to be ineffective, differentiated interventional therapy of multiple-organ-failure syndrome is performed with using a calcium-sensitising agent taken among the cardiac support. The presence of haemodynamic criteria of acute lung injury combined with systemic inflammation response, prolonged renal replacement therapy in continuous veno-venous hemofiltration is performed. It is combined with a simultaneous complex of respiratory kinesiological rehabilitation with differentiated selection of a respiratory support method. On the forth day of artificial pulmonary ventilation, puncture-dilatation tracheostomy is performed. ^ EFFECT: method provides predicting a risk of developing multiple-organ-failure syndrome in a given category of patients at the early stage following the surgery. ^ 2 ex
申请公布号 RU2444379(C2) 申请公布日期 2012.03.10
申请号 RU20100110111 申请日期 2010.03.17
申请人 UCHREZHDENIE ROSSIJSKOJ AKADEMII MEDITSINSKIKH NAUK NAUCHNO-ISSLEDOVATEL'SKIJ INSTITUT KOMPLEKSNYKHPROBLEM SERDECHNO-SOSUDISTYKH ZABOLEVANIJ SIBIRSKOGO OTDELENIJA ROSSIJSKOJ AKADEMII MEDITSINSKIKH NAUK (URAMN NII KPSSZ SO RAMN) 发明人 GRIGOR'EV EVGENIJ VALER'EVICH;PLOTNIKOV GEORGIJ PAVLOVICH;KHAES BORIS L'VOVICH;POPKOV ARTEM NIKOLAEVICH;BARBARASH LEONID SEMENOVICH
分类号 A61B5/02;A61K31/045;A61K31/403;A61M1/34;A61M16/00;A61P7/08 主分类号 A61B5/02
代理机构 代理人
主权项
地址